H. J. Stellbrink
H. J. Stellbrink publishes mostly in Infectious Diseases, Epidemiology and Virology, on topics such as HIV Research and Treatment, HIV/AIDS drug development and treatment and HIV-related health complications and treatments.
- World rank
- #7,109,997 of 7,710,434 ranked researchers
- Rank in Germany
- #346,647 of 364,343
- Works
- 26
- Citations
- 321
- Citations per work
- 12.3
What does H. J. Stellbrink research?
H. J. Stellbrink's work is mostly in Medicine (57%), Immunology and Microbiology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1556.5%
- Medicine1556.5%
- Everything else727.6%
- Life Sciences415.9%
- 1Infectious Diseases26% of their works
- 2Epidemiology17% of their works
- 3Virology10% of their works
- 4Emergency Medicine9% of their works
- 5Parasitology6% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- HIV Research and Treatment
- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS Research and Interventions
- Fungal Infections and Studies
- Tuberculosis Research and Epidemiology
- Immunodeficiency and Autoimmune Disorders
Which keywords describe H. J. Stellbrink's research?
The keywords of their largest research topics: Antiretroviral Therapy, HIV, HIV Infection, Drug Resistance, Immune Response, Vaccine, Diagnosis and Treatment.
- Primary Immunodeficiency
- Tuberculosis
- Histoplasmosis
- Preexposure Prophylaxis
- Pneumocystis
- HIV Transmission
- Nucleoside Analogues
- Antibodies
- Treatment
- Vaccine
- Drug Resistance
- HIV
- Antiretroviral Therapy
- HIV Infection
- Immune Response
- Diagnosis
- AIDS
- Integrase Inhibitors
- Cardiovascular Disease
- Inflammation
- Pneumonia
- Cryptococcal Disease
- Mycobacterium tuberculosis
- Genetic Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Antiretroviral Therapy295 topics
- HIV122 topics
- HIV Infection122 topics
- Drug Resistance102 topics
- Immune Response102 topics
- Vaccine102 topics
- Diagnosis82 topics
- Treatment82 topics
- AIDS71 topic
- Antibodies71 topic
- Integrase Inhibitors71 topic
- Nucleoside Analogues71 topic
- Cardiovascular Disease51 topic
- HIV Transmission51 topic
- Inflammation51 topic
- Pneumocystis51 topic
- Pneumonia51 topic
- Preexposure Prophylaxis51 topic
- Cryptococcal Disease31 topic
- Histoplasmosis31 topic
- Mycobacterium tuberculosis31 topic
- Tuberculosis31 topic
- Genetic Mutations21 topic
- Primary Immunodeficiency21 topic
Where does H. J. Stellbrink work?
H. J. Stellbrink's main affiliation in the publication record is Eppendorf (Germany), Germany.
How many publications and citations does H. J. Stellbrink have?
OpenAlex counts 26 works and 321 citations for H. J. Stellbrink, an h-index of 9, ranking #7,109,997 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about H. J. Stellbrink. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.